Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G | 2024-02-14 | ARMISTICE CAPITAL, LLC | 180 Life Sciences Corp. | 1,112,480 | 10.0% | EDGAR |
SC 13D/A | 2023-04-14 | Feldmann Marc | 180 Life Sciences Corp. | 141,747 | 3.4% | EDGAR |
SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | 180 Life Sciences Corp. | 1,004,406 | 3.0% | EDGAR |
SC 13G/A | 2022-02-09 | VANGUARD INDEX FUNDS | 180 Life Sciences Corp. | 1,004,406 | 3.0% | EDGAR |
SC 13G/A | 2022-02-07 | Nanchahal Jagdeep | 180 Life Sciences Corp. | 1,520,564 | 4.5% | EDGAR |
SC 13D/A | 2021-12-13 | Feldmann Marc | 180 Life Sciences Corp. | 2,834,930 | 8.2% | EDGAR |
SC 13G | 2021-02-10 | VANGUARD GROUP INC | 180 Life Sciences Corp. | 1,179,639 | 6.5% | EDGAR |
SC 13G | 2021-02-08 | VANGUARD INDEX FUNDS | 180 Life Sciences Corp. | 1,069,400 | 5.9% | EDGAR |
SC 13G | 2020-12-31 | BAUER RONALD | 180 Life Sciences Corp. | 2,280,171 | 9.2% | EDGAR |
SC 13D/A | 2020-12-30 | KBL IV SPONSOR LLC | 180 Life Sciences Corp. | 2,223,365 | 9.0% | EDGAR |
SC 13G | 2020-12-29 | BRIDGMAN CRAIG | 180 Life Sciences Corp. | 1,753,543 | 7.4% | EDGAR |
SC 13G | 2020-12-11 | Nanchahal Jagdeep | 180 Life Sciences Corp. | 1,320,615 | 5.3% | EDGAR |
SC 13D | 2020-11-18 | Feldmann Marc | 180 Life Sciences Corp. | 2,596,848 | 10.5% | EDGAR |
SC 13D/A | 2020-11-16 | KBL IV SPONSOR LLC | 180 Life Sciences Corp. | 2,924,323 | 11.9% | EDGAR |
SC 13G | 2020-02-14 | MIZUHO FINANCIAL GROUP INC | KBL MERGER CORP. IV | 421,943 | 5.2% | EDGAR |
SC 13G/A | 2020-02-13 | Weiss Asset Management LP | KBL MERGER CORP. IV | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-12 | BOOTHBAY FUND MANAGEMENT, LLC | KBL MERGER CORP. IV | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-07 | BASSO CAPITAL MANAGEMENT, L.P. | KBL MERGER CORP. IV | 24,800 | 0.3% | EDGAR |
SC 13G | 2020-01-17 | Yakira Capital Management, Inc. | KBL MERGER CORP. IV | 19,125 | 0.4% | EDGAR |
SC 13G/A | 2019-10-10 | OXFORD ASSET MANAGEMENT LLP | KBL MERGER CORP. IV | 132,285 | 1.6% | EDGAR |